BEAM THERAPEUTICS INC (BEAM:NASDAQ)
$24.32 -0.05 (-0.2052%)
Analysed BEAM THERAPEUTICS INC (BEAM:NASDAQ) News Sources
3 Promising Genomics Stocks in the Spotlight in 2026
08-09-2026
yahoo.com
Bank of America Securities Maintains Buy Rating for Beam Therapeutics (BEAM)
15-07-2026
yahoo.com
Cathie Wood Is Buying This Up-and-Coming Biotech Stock. Should You Follow Her Lead?
20-07-2026
fool.com
Beam Therapeutics to Present Updated Data from Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) in Late-Breaking Oral Presentation at the European Respiratory Society (ERS) Congress 2026
23-07-2026
yahoo.com
Beam Therapeutics Reports Second Quarter 2026 Financial Results and Announces First Patient Dosed in Global Pivotal Cohort of BEAM-302 Trial in Alpha-1 Antitrypsin Deficiency (AATD)
04-08-2026
yahoo.com
Beam Therapeutics Inc. (BEAM) Reports Q2 Loss, Lags Revenue Estimates
04-08-2026
yahoo.com
Beam Therapeutics to Participate in Upcoming September 2026 Investor Conferences
31-08-2026
yahoo.com
Beam Therapeutics Appoints Eric Foster as Chief Commercial Officer
01-09-2026
yahoo.com
Beam Therapeutics Targets Accelerated FDA Approval for Base-Editing Treatment
08-09-2026
yahoo.com
Beam Therapeutics (BEAM) Restored AAT Levels. Can BEAM-302 Deliver Clinical Benefit?
10-09-2026
yahoo.com
What is the current price of BEAM THERAPEUTICS INC (BEAM:NASDAQ)?
The current price of BEAM THERAPEUTICS INC (BEAM:NASDAQ) is $24.32.
BEAM THERAPEUTICS INC (BEAM:NASDAQ) absolute price change since previous trading day?
The absolute price change of BEAM THERAPEUTICS INC (BEAM:NASDAQ) since the previous trading day is $-0.05.
BEAM THERAPEUTICS INC (BEAM:NASDAQ) percentage price change since previous trading day?
The percentage price change of BEAM THERAPEUTICS INC (BEAM:NASDAQ) since the previous trading day is -0.2052%.
What is the most recent average sentiment score for BEAM THERAPEUTICS INC (BEAM:NASDAQ)?
The most recent average sentiment score for BEAM THERAPEUTICS INC (BEAM:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for BEAM THERAPEUTICS INC (BEAM:NASDAQ)?
The most recent sentiment for BEAM THERAPEUTICS INC (BEAM:NASDAQ) is .
SEC-8K** Filing Available For BEAM THERAPEUTICS INC (BEAM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.